FGFR1 in metastatic and primary lobular breast carcinoma. A biological rationale for new therapeutic option

被引：0
|
作者：
Brunello, E. [1 ]
Brunelli, M. [1 ]
Nottegar, A. [1 ]
Manfrin, E. [1 ]
Pedron, S. [1 ]
Vittoria, E. [1 ]
Chilosi, M. [1 ]
Gobbo, S. [1 ]
Martignoni, G. [1 ]
Bonetti, F. [1 ]
机构：
[1] Univ Verona, I-37100 Verona, Italy
来源：
VIRCHOWS ARCHIV | 2011年 / 459卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [21] FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
    Turner, Nicholas
    Pearson, Alex
    Sharpe, Rachel
    Lambros, Maryou
    Geyer, Felipe
    Lopez-Garcia, Maria A.
    Natrajan, Rachael
    Marchio, Caterina
    Iorns, Elizabeth
    Mackay, Alan
    Gillett, Cheryl
    Grigoriadis, Anita
    Tutt, Andrew
    Reis-Filho, Jorge S.
    Ashworth, Alan
    CANCER RESEARCH, 2010, 70 (05) : 2085 - 2094
  • [22] Therapeutic rationale for SHP2 phosphatase inhibitors: Targeting drug-resistant breast cancer via blockade of FGFR1 signaling
    Chen, Hao
    Zhang, Sheng
    Zhang, Zhong-Yin
    Wendt, Michael Keith
    CANCER RESEARCH, 2018, 78 (13)
  • [23] FGFR1 Signaling Facilitates Obesity-Driven Pulmonary Outgrowth in Metastatic Breast Cancer
    Cotul, Eylem Kulkoyluoglu
    Safdar, Muhammad Hassan
    Paez, Sebastian Juan
    Kulkarni, Aneesha
    Ayers, Mitchell G.
    Lin, Hang
    Xianyu, Zilin
    Teegarden, Dorothy
    Hursting, Stephen D.
    Wendt, Michael K.
    MOLECULAR CANCER RESEARCH, 2024, 22 (03) : 254 - 267
  • [24] ZNF217 and FGFR1 Amplification in the Progression of In Situ to Invasive Breast Carcinoma
    Jang, M.
    Kim, E. J.
    Choi, Y.
    Lee, H. E.
    Park, S. Y.
    MODERN PATHOLOGY, 2012, 25 : 44A - 44A
  • [25] ZNF217 and FGFR1 Amplification in the Progression of In Situ to Invasive Breast Carcinoma
    Jang, M.
    Kim, E. J.
    Choi, Y.
    Lee, H. E.
    Park, S. Y.
    LABORATORY INVESTIGATION, 2012, 92 : 44A - 44A
  • [26] The combination of the NT157 and sorafenib as a new therapeutic option for hepatocellular carcinoma.
    Gun, Hui
    Wang, Yu
    Yu, S. Z.
    Li, W. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] The Relationship between Leptin, the Leptin Receptor and FGFR1 in Primary Human Breast Tumors
    Boothby-Shoemaker, Wyatt
    Benham, Vanessa
    Paithankar, Shreya
    Shankar, Rama
    Chen, Bin
    Bernard, Jamie J.
    CELLS, 2020, 9 (10)
  • [28] FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma
    Koole, Koos
    Brunen, Diede
    van Kempen, Pauline M. W.
    Noorlag, Rob
    de Bree, Remco
    Lieftink, Cor
    van Es, Robert J. J.
    Bernards, Rene
    Willems, Stefan M.
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3884 - 3893
  • [29] Metastatic lobular carcinoma of breast mimics primary cervix carcinoma: two case reports and a review of the literature
    Lokadasan, Rajitha
    Ratheesan, K.
    Sukumaran, Renu
    Nair, Sindhu P.
    ECANCERMEDICALSCIENCE, 2015, 9
  • [30] FGFR1 amplification in metastatic squamous cell carcinoma of the head and neck: A potential target for a rational therapy?
    Goeke, F.
    Franzen, A.
    Menon, R.
    Schroeck, A.
    Kirsten, R.
    Boehm, D.
    Vogel, W.
    Bootz, F.
    Perner, S.
    VIRCHOWS ARCHIV, 2012, 461 : S49 - S49
12345